Risk estimation versus screening performance: A comparison of six risk algorithms for cardiovascular disease

Journal of Medical Screening

Volumn 19, Issue 4, 2012, Pages 201-205

  Simmonds, Mark C ^a   Jwald, Nicholas ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; COMPARATIVE STUDY; EVALUATION; FEMALE; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; MALE; MASS SCREENING; MIDDLE AGED; PRODUCTIVITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICS;

ADULT; AGED; ALGORITHMS; CARDIOVASCULAR DISEASES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; EFFICIENCY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84878274994     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2012.012076     Document Type: Article

References (16)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-1757
2. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-1425
3. Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, et al. Effects of the polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341-1351
4. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE clinical guidance 67, 2008
5. Anderson K, Odell P, Wilson P, Kannel W. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-298
6. Wald NJ, Simmonds M, Morris JK. Screening for future cardiovascular disease using age alone compared with multiple risk factors and age. PLoS One 2011;6:e18742
7. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847
8. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds risk score for men. Circulation 2008;118:2243-2251
9. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. JAMA 2007;297:611-619
10. Conroy RM, Pyorala K, Fitzgerald AP, et al. estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2002;24:987-1003
11. Woodward M, Bridle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Health Extended Cohort (SHHEC). Heart 2007;93:172-176
12. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136
13. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:a332
14. Office for National Statistics. 2005. Mortality Statistics, Series DH2 Number 32. HMSO, London, UK, 2007
15. Health Survey for England, 2003. The Stationery Office, UK, 2003
16. Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ 2010;340:c2442